Contact
searchSearch
HMP Global

COVID-19

Featured Article

News
COVID-19 Infection Linked to Increased Risk of Skin Conditions
01/08/2025
Grace Taylor, MS, MA
A recent study found that COVID-19 infection significantly increases the risk of developing skin conditions such as vitiligo, chronic urticaria, alopecia areata, and herpes zoster.
A recent study found that COVID-19 infection significantly increases the risk of developing skin conditions such as vitiligo, chronic urticaria, alopecia areata, and herpes zoster.
A recent study found that...
01/08/2025
First Report Managed Care
News
Financial Hardships Associated With Long COVID Across Income and Education Levels
12/19/2024
Juliet Gallagher
A study published in Health Services Research analyzing data from the 2022 Behavioral Risk Factor Surveillance System (BRFSS) has revealed a significant association between long COVID and financial hardships.
A study published in Health Services Research analyzing data from the 2022 Behavioral Risk Factor Surveillance System (BRFSS) has revealed a significant association between long COVID and financial hardships.
A study published in Health...
12/19/2024
First Report Managed Care
News
Effectiveness of SARS-CoV-2 Vaccination Among Health Care Workers
12/17/2024
Hannah Musick
A comprehensive analysis of SARS-CoV-2 vaccination in health care workers shows high levels of protection against infection, symptomatic infection, and hospitalization with evidence of waning immunity over time.
A comprehensive analysis of SARS-CoV-2 vaccination in health care workers shows high levels of protection against infection, symptomatic infection, and hospitalization with evidence of waning immunity over time.
A comprehensive analysis of...
12/17/2024
First Report Managed Care
News
Patients With MS on Ocrelizumab and Rituximab May Have Higher Risk of SARS-CoV-2 Infection Compared to Ofatumumab
05/28/2024
Hannah Musick
Recent research found that patients on ocrelizumab and rituximab are at a higher risk of contracting SARS-CoV-2 despite being vaccinated, compared to those on ofatumumab.
Recent research found that patients on ocrelizumab and rituximab are at a higher risk of contracting SARS-CoV-2 despite being vaccinated, compared to those on ofatumumab.
Recent research found that...
05/28/2024
First Report Managed Care
Headshots
Commentary
Harnessing Innovation to Improve Maternal Health
04/09/2024

Britteny Matero, partner and senior vice president, Market Access, Innsena, and Jaime Bland, DNP, RN, president and chief executive officer, CyncHealth

Britteny Matero, partner and senior v...
The US faces a critical maternal health crisis, with high maternal mortality rates exacerbated by COVID-19 and racial disparities. Institutional changes are needed to prevent these largely preventable deaths, and two experts highlight...
The US faces a critical maternal health crisis, with high maternal mortality rates exacerbated by COVID-19 and racial disparities. Institutional changes are needed to prevent these largely preventable deaths, and two experts highlight...
The US faces a critical maternal...
04/09/2024
First Report Managed Care
Conference Insider
Down Syndrome Associated With Higher COVID-19 Risk in Pediatric Patients With Hematologic Malignancies
04/13/2023
Maria Asimopoulos
Jennifer Wilkes, MD, MSCE, discusses her research exploring the risk of COVID-19 infection and complications in pediatric patients with hematologic malignancies and Down syndrome.
Jennifer Wilkes, MD, MSCE, discusses her research exploring the risk of COVID-19 infection and complications in pediatric patients with hematologic malignancies and Down syndrome.
Jennifer Wilkes, MD, MSCE,...
04/13/2023
First Report Managed Care
News
Risk of Fatal Overdose Decreased With Expanded Access to Telehealth, Medications for OUD During Pandemic
04/03/2023
Hannah Musick
Fatal drug overdoses were less likely among Medicare beneficiaries during the COVID-19 pandemic due to increased access to telehealth services and medications for opioid use disorder.
Fatal drug overdoses were less likely among Medicare beneficiaries during the COVID-19 pandemic due to increased access to telehealth services and medications for opioid use disorder.
Fatal drug overdoses were less...
04/03/2023
First Report Managed Care
News
SDoH Impact COVID-19 Vaccination Rates Among Patients With Cancer
03/27/2023
Hannah Musick
Age, cancer type, and comorbidity status were among several significant factors driving COVID-19 vaccination rates for patients with cancer, new findings show.
Age, cancer type, and comorbidity status were among several significant factors driving COVID-19 vaccination rates for patients with cancer, new findings show.
Age, cancer type, and...
03/27/2023
First Report Managed Care
Conference Coverage
Measuring the Pandemic's Impact on Oral Oncolytic Adherence
03/24/2023
Maria Asimopoulos
Researchers at AMCP 2023 studied the number of prescription fills and therapy changes to determine how COVID-19 impacted adherence to oral oncolytic agents.
Researchers at AMCP 2023 studied the number of prescription fills and therapy changes to determine how COVID-19 impacted adherence to oral oncolytic agents.
Researchers at AMCP 2023 studied...
03/24/2023
First Report Managed Care
News
Woman Develops Retroperitoneal Fibrosis Following COVID-19 mRNA Vaccination
03/23/2023
Jolynn Tumolo
A 58-year-old woman developed retroperitoneal fibrosis 5 weeks after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine, findings show.
A 58-year-old woman developed retroperitoneal fibrosis 5 weeks after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine, findings show.
A 58-year-old woman developed...
03/23/2023
First Report Managed Care
News
High-Throughput Assay Tracks Range of SARS-CoV-2 Vaccination Responses
03/22/2023
Jolynn Tumolo
New research demonstrated an immunoassay was efficacious for tracking antibody responses to SARS-CoV-2 vaccination across all ages and infection history.
New research demonstrated an immunoassay was efficacious for tracking antibody responses to SARS-CoV-2 vaccination across all ages and infection history.
New research demonstrated an...
03/22/2023
First Report Managed Care

Newsfeed

News
COVID-19 Infection Linked to Increased Risk of Skin Conditions
01/08/2025
Grace Taylor, MS, MA
A recent study found that COVID-19 infection significantly increases the risk of developing skin conditions such as vitiligo, chronic urticaria, alopecia areata, and herpes zoster.
A recent study found that COVID-19 infection significantly increases the risk of developing skin conditions such as vitiligo, chronic urticaria, alopecia areata, and herpes zoster.
A recent study found that...
01/08/2025
First Report Managed Care
News
Financial Hardships Associated With Long COVID Across Income and Education Levels
12/19/2024
Juliet Gallagher
A study published in Health Services Research analyzing data from the 2022 Behavioral Risk Factor Surveillance System (BRFSS) has revealed a significant association between long COVID and financial hardships.
A study published in Health Services Research analyzing data from the 2022 Behavioral Risk Factor Surveillance System (BRFSS) has revealed a significant association between long COVID and financial hardships.
A study published in Health...
12/19/2024
First Report Managed Care
News
Effectiveness of SARS-CoV-2 Vaccination Among Health Care Workers
12/17/2024
Hannah Musick
A comprehensive analysis of SARS-CoV-2 vaccination in health care workers shows high levels of protection against infection, symptomatic infection, and hospitalization with evidence of waning immunity over time.
A comprehensive analysis of SARS-CoV-2 vaccination in health care workers shows high levels of protection against infection, symptomatic infection, and hospitalization with evidence of waning immunity over time.
A comprehensive analysis of...
12/17/2024
First Report Managed Care
News
Patients With MS on Ocrelizumab and Rituximab May Have Higher Risk of SARS-CoV-2 Infection Compared to Ofatumumab
05/28/2024
Hannah Musick
Recent research found that patients on ocrelizumab and rituximab are at a higher risk of contracting SARS-CoV-2 despite being vaccinated, compared to those on ofatumumab.
Recent research found that patients on ocrelizumab and rituximab are at a higher risk of contracting SARS-CoV-2 despite being vaccinated, compared to those on ofatumumab.
Recent research found that...
05/28/2024
First Report Managed Care
News
Risk of Fatal Overdose Decreased With Expanded Access to Telehealth, Medications for OUD During Pandemic
04/03/2023
Hannah Musick
Fatal drug overdoses were less likely among Medicare beneficiaries during the COVID-19 pandemic due to increased access to telehealth services and medications for opioid use disorder.
Fatal drug overdoses were less likely among Medicare beneficiaries during the COVID-19 pandemic due to increased access to telehealth services and medications for opioid use disorder.
Fatal drug overdoses were less...
04/03/2023
First Report Managed Care
News
SDoH Impact COVID-19 Vaccination Rates Among Patients With Cancer
03/27/2023
Hannah Musick
Age, cancer type, and comorbidity status were among several significant factors driving COVID-19 vaccination rates for patients with cancer, new findings show.
Age, cancer type, and comorbidity status were among several significant factors driving COVID-19 vaccination rates for patients with cancer, new findings show.
Age, cancer type, and...
03/27/2023
First Report Managed Care
News
Woman Develops Retroperitoneal Fibrosis Following COVID-19 mRNA Vaccination
03/23/2023
Jolynn Tumolo
A 58-year-old woman developed retroperitoneal fibrosis 5 weeks after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine, findings show.
A 58-year-old woman developed retroperitoneal fibrosis 5 weeks after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine, findings show.
A 58-year-old woman developed...
03/23/2023
First Report Managed Care
News
High-Throughput Assay Tracks Range of SARS-CoV-2 Vaccination Responses
03/22/2023
Jolynn Tumolo
New research demonstrated an immunoassay was efficacious for tracking antibody responses to SARS-CoV-2 vaccination across all ages and infection history.
New research demonstrated an immunoassay was efficacious for tracking antibody responses to SARS-CoV-2 vaccination across all ages and infection history.
New research demonstrated an...
03/22/2023
First Report Managed Care
News
Meta-Analysis Supports COVID-19 Vaccines for Adults of All Ages
02/22/2023
Jolynn Tumolo
A new meta-analysis reveals that COVID-19 vaccines can create immunity against SARS-CoV-2 infection in adults of all ages and may require extra attention for older individuals.
A new meta-analysis reveals that COVID-19 vaccines can create immunity against SARS-CoV-2 infection in adults of all ages and may require extra attention for older individuals.
A new meta-analysis reveals that...
02/22/2023
First Report Managed Care
News
Contracting COVID-19 Almost Doubles Long-Term Mortality Rate
02/21/2023
Hannah Musick
Patients who have contracted COVID-19 are at risk for a higher mortality rate than those who have never contracted the disease, findings show.
Patients who have contracted COVID-19 are at risk for a higher mortality rate than those who have never contracted the disease, findings show.
Patients who have contracted...
02/21/2023
First Report Managed Care
News
Anemia Associated With Reduced Ruxolitinib Dosing and Poor Survival in MF
09/28/2026
Rebecca Amrick
Researchers found that among patients with myelofibrosis (MF), anemia was associated with reduced doses of ruxolitinib and worse survival outcomes, highlighting the need for proactive strategies aimed at mitigating the impact and progression...
Researchers found that among patients with myelofibrosis (MF), anemia was associated with reduced doses of ruxolitinib and worse survival outcomes, highlighting the need for proactive strategies aimed at mitigating the impact and progression...
Researchers found that among...
09/28/2026
First Report Managed Care
News
Timing of Bispecific Antibody Therapy After CAR T-Cell May Affect Outcomes Among Patients With R/R FL
09/28/2026
Rebecca Amrick
Researchers found that patients with relapsed or refractory follicular lymphoma (R/R FL) achieved short but clinically significant responses to bispecific antibodies following chimeric antigen receptor (CAR) T-cell therapy, highlighting the...
Researchers found that patients with relapsed or refractory follicular lymphoma (R/R FL) achieved short but clinically significant responses to bispecific antibodies following chimeric antigen receptor (CAR) T-cell therapy, highlighting the...
Researchers found that patients...
09/28/2026
First Report Managed Care
Behind the Bill
All 50 States Move to Join Medicaid Drug Pricing Model
09/25/2026
Grace Taylor, MS, MA
All 50 states are moving to participate in a Medicaid drug pricing model that the Trump administration projects could lower prescription drug spending, though questions remain about the magnitude and durability of the savings.
All 50 states are moving to participate in a Medicaid drug pricing model that the Trump administration projects could lower prescription drug spending, though questions remain about the magnitude and durability of the savings.
All 50 states are moving to...
09/25/2026
First Report Managed Care
News
Obesity Treatments Project Long-Term Social Value for US Employers and Employees
09/25/2026
Rebecca Amrick
Researchers found that evidence-based obesity treatments may reduce chronic disease while generating long-term medical savings, productivity gain, and positive returns on investment among commercially insured US adults.
Researchers found that evidence-based obesity treatments may reduce chronic disease while generating long-term medical savings, productivity gain, and positive returns on investment among commercially insured US adults.
Researchers found that...
09/25/2026
First Report Managed Care
News
Sustained Full-Dose Ruxolitinib Shows Manageable Toxicity Among Patients With MF
09/25/2026
Rebecca Amrick
Researchers found that sustained exposure to full-dose ruxolitinib was associated with spleen reduction and manageable toxicity among select patients with myelofibrosis (MF).
Researchers found that sustained exposure to full-dose ruxolitinib was associated with spleen reduction and manageable toxicity among select patients with myelofibrosis (MF).
Researchers found that sustained...
09/25/2026
First Report Managed Care
News
Higher Out-of-Pocket Costs Linked to Lower Semaglutide Adherence in Obesity
09/23/2026
Hannah Musick
Higher out-of-pocket costs were associated with lower semaglutide adherence among commercially insured adults with obesity, with nonadherence increasing more substantially when costs exceeded approximately $75 per 30-day supply.
Higher out-of-pocket costs were associated with lower semaglutide adherence among commercially insured adults with obesity, with nonadherence increasing more substantially when costs exceeded approximately $75 per 30-day supply.
Higher out-of-pocket costs were...
09/23/2026
First Report Managed Care
News
Minimal Disease Activity Linked to Fewer Flares, Health Care Visits in Atopic Dermatitis
09/23/2026
Hannah Musick
Adults with moderate-to-severe atopic dermatitis who achieved minimal disease activity experienced fewer and shorter flares, fewer health care visits, and greater perceived disease control than patients who did not meet combined clinician-...
Adults with moderate-to-severe atopic dermatitis who achieved minimal disease activity experienced fewer and shorter flares, fewer health care visits, and greater perceived disease control than patients who did not meet combined clinician-...
Adults with moderate-to-severe...
09/23/2026
First Report Managed Care
News
Later Lines of Therapy Drive Economic Burden in Indolent Non-Hodgkin Lymphomas
09/23/2026
Rebecca Amrick
Researchers found that indolent non-Hodgkin lymphomas, specifically follicular lymphoma, Waldenström macroglobulinemia, and marginal zone lymphoma, are associated with increased health care utilization and care costs during later lines of...
Researchers found that indolent non-Hodgkin lymphomas, specifically follicular lymphoma, Waldenström macroglobulinemia, and marginal zone lymphoma, are associated with increased health care utilization and care costs during later lines of...
Researchers found that indolent...
09/23/2026
First Report Managed Care
News
Combining Anemia Medications With Ruxolitinib in Patients With Myelofibrosis
09/23/2026
Rebecca Amrick
A post hoc analysis of the JUMP clinical trial found that anemia medications can be used in combination with ruxolitinib among patients with myelofibrosis without compromising treatment effectiveness.
A post hoc analysis of the JUMP clinical trial found that anemia medications can be used in combination with ruxolitinib among patients with myelofibrosis without compromising treatment effectiveness.
A post hoc analysis of the JUMP...
09/23/2026
First Report Managed Care
News
Subcutaneous Mosunetuzumab Shows Durable Responses in Relapsed/Refractory Follicular Lymphoma
09/22/2026
Hannah Musick
Subcutaneous mosunetuzumab demonstrated durable responses and predominantly low-grade cytokine release syndrome in patients with relapsed/refractory follicular lymphoma, with efficacy outcomes similar to intravenous administration.
Subcutaneous mosunetuzumab demonstrated durable responses and predominantly low-grade cytokine release syndrome in patients with relapsed/refractory follicular lymphoma, with efficacy outcomes similar to intravenous administration.
Subcutaneous mosunetuzumab...
09/22/2026
First Report Managed Care

Videos

Videos
Factors to Consider When Differentiating Between COVID and Allergy Symptoms
07/21/2020
Lakiea Wright, MD, explains how health care professionals can identify allergic asthma triggers in the age of social distancing and highlights factors that should be considered when differentiating between COVID-19 and general allergy...
Lakiea Wright, MD, explains how health care professionals can identify allergic asthma triggers in the age of social distancing and highlights factors that should be considered when differentiating between COVID-19 and general allergy...
Lakiea Wright, MD, explains how...
07/21/2020
First Report Managed Care
Videos
How I Practice Now: Ensuring Patients Understand the Proper Use of Telehealth
04/02/2020
Nana Duffy, MD, dermatologist, Rochester Regional Health, explains the importance of ensuring patients understand how to use telehealth properly and to its full capacity.
Nana Duffy, MD, dermatologist, Rochester Regional Health, explains the importance of ensuring patients understand how to use telehealth properly and to its full capacity.
Nana Duffy, MD, dermatologist,...
04/02/2020
First Report Managed Care
PIPELINE PROJECTIONS
The Evolving Alzheimer Disease Treatment Landscape: Anti-Amyloid Therapies and Beyond
07/21/2026
Roy Moore
Roy Moore explores the evolving Alzheimer's disease pipeline, highlighting the promise of anti-amyloid therapies, emerging competitors, and the challenges ahead.
Roy Moore explores the evolving Alzheimer's disease pipeline, highlighting the promise of anti-amyloid therapies, emerging competitors, and the challenges ahead.
Roy Moore explores the evolving...
07/21/2026
First Report Managed Care
BI FRMC KOL video
Videos
Beyond FVC: What FIBRONEER-ILD Means for Outcomes, Patients, and Access in PPF
07/01/2026
Toby Maher, MD, PhD
In this expert commentary, Dr Toby Maher discusses the evolving treatment landscape in progressive pulmonary fibrosis (PPF) and the potential implications of the longer-term FIBRONEER-ILD trial findings. He explores how nerandomilast may...
In this expert commentary, Dr Toby Maher discusses the evolving treatment landscape in progressive pulmonary fibrosis (PPF) and the potential implications of the longer-term FIBRONEER-ILD trial findings. He explores how nerandomilast may...
In this expert commentary, Dr...
07/01/2026
First Report Managed Care
Nephrology, kidney disease
Managed Care Insights
The Evolving Nephrology Landscape: Treatment, Innovation, and Policy: Part 3
05/29/2026
Suzanne Watnick, MD
Suzanne Watnick, MD, explains why earlier chronic kidney disease detection, broader access to proven therapies, and reimbursement policies that support innovation are critical to improving kidney care outcomes and reducing progression to...
Suzanne Watnick, MD, explains why earlier chronic kidney disease detection, broader access to proven therapies, and reimbursement policies that support innovation are critical to improving kidney care outcomes and reducing progression to...
Suzanne Watnick, MD, explains...
05/29/2026
First Report Managed Care
Nephrology, kidney disease
Managed Care Insights
The Evolving Nephrology Landscape: Treatment, Innovation, and Policy: Part 2
05/29/2026
Suzanne Watnick, MD
Dr Suzanne Watnick examines how greater investment, equitable policies, and stakeholder collaboration will be essential to ensuring that emerging kidney therapies improve outcomes without widening existing disparities in care.
Dr Suzanne Watnick examines how greater investment, equitable policies, and stakeholder collaboration will be essential to ensuring that emerging kidney therapies improve outcomes without widening existing disparities in care.
Dr Suzanne Watnick examines how...
05/29/2026
First Report Managed Care
Nephrology, kidney disease
Managed Care Insights
The Evolving Nephrology Landscape: Treatment, Innovation, and Policy
05/29/2026
Suzanne Watnick, MD
Dr Suzanne Watnick explains how value-based kidney care can improve outcomes by shifting focus upstream to earlier chronic kidney disease intervention, prevention, and long-term cost savings.
Dr Suzanne Watnick explains how value-based kidney care can improve outcomes by shifting focus upstream to earlier chronic kidney disease intervention, prevention, and long-term cost savings.
Dr Suzanne Watnick explains how...
05/29/2026
First Report Managed Care
Advanced Squamous Cell Carcinoma of the Anal Canal
Videos
Evaluating Retifanlimab for Advanced Squamous Cell Carcinoma of the Anal Canal in the Frontline Setting
03/31/2026
Lingbin Meng, MD, PhD
Lingbin Meng, MD, discusses how adding retifanlimab to chemotherapy may reshape frontline treatment for advanced squamous cell carcinoma of the anal canal.
Lingbin Meng, MD, discusses how adding retifanlimab to chemotherapy may reshape frontline treatment for advanced squamous cell carcinoma of the anal canal.
Lingbin Meng, MD, discusses how...
03/31/2026
Journal of Clinical Pathways
Al B. Benson, III, MD, FACP, FASCO
Videos
First-Line Immunotherapy in Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC): Evidence Review
03/31/2026
Al B. Benson, III, MD, FACP, FASCO
Dr Benson reviews the epidemiology and unmet clinical need in advanced squamous cell carcinoma of the anal canal (SCAC) and examines the evolving role of immunotherapy in the first-line setting. He also contextualizes recent regulatory and...
Dr Benson reviews the epidemiology and unmet clinical need in advanced squamous cell carcinoma of the anal canal (SCAC) and examines the evolving role of immunotherapy in the first-line setting. He also contextualizes recent regulatory and...
Dr Benson reviews the...
03/31/2026
First Report Managed Care
Videos
Can Agentic AI Deliver? Rethinking Innovation, ROI, and Risk in Managed Care
03/30/2026
Andy De, CMO
A guest expert explains why generative AI has largely stalled in health care and argues that agentic AI—focused on automating workflows and driving action—offers a more practical path to measurable ROI, improved clinician productivity, and...
A guest expert explains why generative AI has largely stalled in health care and argues that agentic AI—focused on automating workflows and driving action—offers a more practical path to measurable ROI, improved clinician productivity, and...
A guest expert explains why...
03/30/2026
First Report Managed Care
PIPELINE PROJECTIONS
Emerging Therapies Reshaping Atopic Dermatitis Care
03/26/2026
Roy Moore
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly...
03/26/2026
First Report Managed Care
ALH
Videos
Redefining gMG Management: Pt II
03/12/2026
Amanda L. Hernandez, MD, PhD
In the second part of this interview, Amanda Hernandez, MD, PhD, examines the role and limitations of Myasthenia Gravis Activities of Daily Living (MG-ADL)  and other outcome measures in myasthenia gravis, emphasizing the importance of...
In the second part of this interview, Amanda Hernandez, MD, PhD, examines the role and limitations of Myasthenia Gravis Activities of Daily Living (MG-ADL)  and other outcome measures in myasthenia gravis, emphasizing the importance of...
In the second part of this...
03/12/2026
First Report Managed Care

Podcasts

Podcasts
Identifying the Benefits of Rapid At-Home Diagnostic Testing and How These Can Communicate With PCPs, Infectious Disease Professionals
10/25/2020
Ron Chiarello, PhD, CEO, Alveo Technologies, discusses a recent collaboration the company began with Janssen—where together they are working to improve and expand an at-home self-testing platform for viral infectious diseases—and explains why...
Ron Chiarello, PhD, CEO, Alveo Technologies, discusses a recent collaboration the company began with Janssen—where together they are working to improve and expand an at-home self-testing platform for viral infectious diseases—and explains why...
Ron Chiarello, PhD, CEO, Alveo...
10/25/2020
First Report Managed Care
BI FRMC Clinical Outcomes That Matter
Podcasts
Clinical Outcomes That Matter: FIBRONEER-ILD and the Future of PPF Management
06/25/2026
Toby Maher, MD, PhD
In this expert commentary, Dr Toby Maher discusses the evolving treatment landscape in progressive pulmonary fibrosis (PPF) and the implications of the extended follow-up findings from the FIBRONEER-ILD trial. He explores the potential role...
In this expert commentary, Dr Toby Maher discusses the evolving treatment landscape in progressive pulmonary fibrosis (PPF) and the implications of the extended follow-up findings from the FIBRONEER-ILD trial. He explores the potential role...
In this expert commentary, Dr...
06/25/2026
First Report Managed Care
Gaballa
Podcasts
Real-World Applications of Fixed-Duration Therapy in CLL: Accessibility, Cost, and Patient Preference
10/09/2025
Sameh Gaballa, MD
In this interview, Dr Sameh Gaballa of Moffitt Cancer Center discusses the expanding landscape of chronic lymphocytic leukemia (CLL) therapy, highlighting the role of fixed-duration regimens, real-world implementation challenges, and...
In this interview, Dr Sameh Gaballa of Moffitt Cancer Center discusses the expanding landscape of chronic lymphocytic leukemia (CLL) therapy, highlighting the role of fixed-duration regimens, real-world implementation challenges, and...
In this interview, Dr Sameh...
10/09/2025
First Report Managed Care
Bhat Headshot
Podcasts
Time-Limited Therapy in CLL: A Value-Based Approach to Modern Oncology
07/08/2025
Seema A. Bhat, MD
Dr Seema Bhat explores how fixed-duration therapies are reshaping chronic lymphocytic leukemia (CLL) treatment, offering real-world insight into clinical decision-making, economic impact, and patient quality of life.
Dr Seema Bhat explores how fixed-duration therapies are reshaping chronic lymphocytic leukemia (CLL) treatment, offering real-world insight into clinical decision-making, economic impact, and patient quality of life.
Dr Seema Bhat explores how...
07/08/2025
First Report Managed Care
Robbins
Podcasts
Improving Access to CGRP Therapies for Effective Migraine Treatment
12/12/2024
Explore the challenges patients face in accessing CGRP therapies for migraines, strategies to streamline treatment effectiveness, and the crucial role of health care providers in navigating access barriers and aligning clinical guidelines...
Explore the challenges patients face in accessing CGRP therapies for migraines, strategies to streamline treatment effectiveness, and the crucial role of health care providers in navigating access barriers and aligning clinical guidelines...
Explore the challenges patients...
12/12/2024
First Report Managed Care
LMW
Podcasts
Understanding Early CGRP Therapy Initiation in Migraine Treatment
11/22/2024
Lucy Myint-Wilks, BMBS, MSc, MRCS
Explore the latest advancements in migraine research, treatment options, cost-effectiveness, and the role of technology in managing migraines in this informative episode.
Explore the latest advancements in migraine research, treatment options, cost-effectiveness, and the role of technology in managing migraines in this informative episode.
Explore the latest advancements...
11/22/2024
First Report Managed Care
Ed
Podcasts
Improving Adherence With Long-Acting Antiretroviral Therapy for HIV
11/15/2024
Edmund J. Pezalla, MD
Join our in-depth discussion about the challenges of HIV treatment, the importance of adherence to antiretroviral therapy, and how long-acting ART can improve treatment outcomes.
Join our in-depth discussion about the challenges of HIV treatment, the importance of adherence to antiretroviral therapy, and how long-acting ART can improve treatment outcomes.
Join our in-depth discussion...
11/15/2024
First Report Managed Care
Sid Devarakonda
Podcasts
Frontline Treatment Landscape Advancements for Non-Small Cell Lung Cancer
08/28/2024
Sid Devarakonda, MD
Tune in as we speak with a guest oncology expert about the progress in treating non-small cell lung cancer, targeted therapies and immunotherapy, and the challenges of early detection and screening options covered by health plans.
Tune in as we speak with a guest oncology expert about the progress in treating non-small cell lung cancer, targeted therapies and immunotherapy, and the challenges of early detection and screening options covered by health plans.
Tune in as we speak with a guest...
08/28/2024
First Report Managed Care
Owens
Podcasts
Understanding the Impact of Formulary Exclusions on Medication Adherence
03/28/2024
Gary Owens, MD
Join us as guest expert Gary Owens discusses how formulary exclusions can impact patient medication adherence and lead to adverse economic outcomes, making the need for non-medical switching and formulary exception requests an important issue...
Join us as guest expert Gary Owens discusses how formulary exclusions can impact patient medication adherence and lead to adverse economic outcomes, making the need for non-medical switching and formulary exception requests an important issue...
Join us as guest expert Gary...
03/28/2024
First Report Managed Care
Stravers
Podcasts
The Impact of Data Theft on Patient Care: Insights from a Health Care Cybersecurity Professional
03/01/2024

Featuring Jeff Stravers, virtual chief information officer at ANATOMY_IT. 

Featuring Jeff Stravers, virtual...
Health care cybersecurity is an increasing priority as cyber criminals’ tactics become more sophisticated and data breaches can erode patient trust and jeopardize patient safety.
Health care cybersecurity is an increasing priority as cyber criminals’ tactics become more sophisticated and data breaches can erode patient trust and jeopardize patient safety.
Health care cybersecurity is an...
03/01/2024
First Report Managed Care
Prajapati Podcast
Podcasts
Standardizing the Field of Digital Medicine: Insights from an Industry Expert
02/27/2024
Yash Prajapati
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates Consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates Consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care

Insights

Headshots
Commentary
Harnessing Innovation to Improve Maternal Health
04/09/2024

Britteny Matero, partner and senior vice president, Market Access, Innsena, and Jaime Bland, DNP, RN, president and chief executive officer, CyncHealth

Britteny Matero, partner and senior v...
The US faces a critical maternal health crisis, with high maternal mortality rates exacerbated by COVID-19 and racial disparities. Institutional changes are needed to prevent these largely preventable deaths, and two experts highlight...
The US faces a critical maternal health crisis, with high maternal mortality rates exacerbated by COVID-19 and racial disparities. Institutional changes are needed to prevent these largely preventable deaths, and two experts highlight...
The US faces a critical maternal...
04/09/2024
First Report Managed Care
Archelle Georgiou, MD CaringBridge
Commentary
How Connection and Social Support Help Those Suffering From Long COVID
08/05/2021
Archelle Georgiou, MD
Archelle Georgiou, MD, discusses long COVID—which impacts those experiencing symptoms for weeks or months after recovering from the disease—and explains what those in the health care industry should know and why love and support can help...
Archelle Georgiou, MD, discusses long COVID—which impacts those experiencing symptoms for weeks or months after recovering from the disease—and explains what those in the health care industry should know and why love and support can help...
Archelle Georgiou, MD, discusses...
08/05/2021
First Report Managed Care
Population Points
A COVID-19 Hangover
06/18/2021
Mitch Kaminski, MD, MBA
Mitch Kaminski, MD, MBA, editor-in-chief, Population Health Learning Network, discusses the after-effects of the pandemic as cases have begun to drop, highlights how “a new normal” may challenge our fee-for-service based health care system,...
Mitch Kaminski, MD, MBA, editor-in-chief, Population Health Learning Network, discusses the after-effects of the pandemic as cases have begun to drop, highlights how “a new normal” may challenge our fee-for-service based health care system,...
Mitch Kaminski, MD, MBA,...
06/18/2021
First Report Managed Care
Commentary
Looking Ahead: Three Imperatives for Recovering Health Systems
02/25/2021
"While hospitals dealt with the sudden patient influx caused by COVID-19, distributors confronted the challenge of maintaining a steady supply of essential products and medications to treat a disease that seemed almost invincible," said...
"While hospitals dealt with the sudden patient influx caused by COVID-19, distributors confronted the challenge of maintaining a steady supply of essential products and medications to treat a disease that seemed almost invincible," said...
"While hospitals dealt with the...
02/25/2021
First Report Managed Care
Population Points
Confronting Vaccine Hesitancy
02/12/2021
Mitch Kaminski, MD, MBA
Mitch Kaminski, MD, MBA, editor-in-chief, discusses his recent experience with a patient regarding vaccine hesitancy, breaks down the history of anti-vaccine sentiment, and explains why vaccine hesitancy is about much more than just the...
Mitch Kaminski, MD, MBA, editor-in-chief, discusses his recent experience with a patient regarding vaccine hesitancy, breaks down the history of anti-vaccine sentiment, and explains why vaccine hesitancy is about much more than just the...
Mitch Kaminski, MD, MBA,...
02/12/2021
First Report Managed Care
Podcasts
Identifying the Benefits of Rapid At-Home Diagnostic Testing and How These Can Communicate With PCPs, Infectious Disease Professionals
10/25/2020
Ron Chiarello, PhD, CEO, Alveo Technologies, discusses a recent collaboration the company began with Janssen—where together they are working to improve and expand an at-home self-testing platform for viral infectious diseases—and explains why...
Ron Chiarello, PhD, CEO, Alveo Technologies, discusses a recent collaboration the company began with Janssen—where together they are working to improve and expand an at-home self-testing platform for viral infectious diseases—and explains why...
Ron Chiarello, PhD, CEO, Alveo...
10/25/2020
First Report Managed Care
Videos
Factors to Consider When Differentiating Between COVID and Allergy Symptoms
07/21/2020
Lakiea Wright, MD, explains how health care professionals can identify allergic asthma triggers in the age of social distancing and highlights factors that should be considered when differentiating between COVID-19 and general allergy...
Lakiea Wright, MD, explains how health care professionals can identify allergic asthma triggers in the age of social distancing and highlights factors that should be considered when differentiating between COVID-19 and general allergy...
Lakiea Wright, MD, explains how...
07/21/2020
First Report Managed Care
Videos
How I Practice Now: Ensuring Patients Understand the Proper Use of Telehealth
04/02/2020
Nana Duffy, MD, dermatologist, Rochester Regional Health, explains the importance of ensuring patients understand how to use telehealth properly and to its full capacity.
Nana Duffy, MD, dermatologist, Rochester Regional Health, explains the importance of ensuring patients understand how to use telehealth properly and to its full capacity.
Nana Duffy, MD, dermatologist,...
04/02/2020
First Report Managed Care

Interactive Features

Pipeline Projections

PIPELINE PROJECTIONS
The Evolving Alzheimer Disease Treatment Landscape: Anti-Amyloid Therapies and Beyond
07/21/2026
Roy Moore
Roy Moore explores the evolving Alzheimer's disease pipeline, highlighting the promise of anti-amyloid therapies, emerging competitors, and the challenges ahead.
Roy Moore explores the evolving Alzheimer's disease pipeline, highlighting the promise of anti-amyloid therapies, emerging competitors, and the challenges ahead.
Roy Moore explores the evolving...
07/21/2026
First Report Managed Care
PIPELINE PROJECTIONS
Emerging Therapies Reshaping Atopic Dermatitis Care
03/26/2026
Roy Moore
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly...
03/26/2026
First Report Managed Care
Pipe
Pipeline Projections
Emerging Migraine Treatments Challenge a Mature Market
11/20/2025
Roy Moore
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market...
11/20/2025
First Report Managed Care
Pipeline Projections
Pipeline Projections
Redefining Asthma Management With Emerging Anti-Inflammatories
10/01/2025
Roy Moore
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access...
10/01/2025
First Report Managed Care
Pipeline Projections
The Shift in MS Care as Biologics and BTK Inhibitors Advance
07/25/2025
Roy Moore
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline...
07/25/2025
First Report Managed Care

Subscribe to receive the latest updates in managed care!

First Report Managed Care Newsletter

Behind the Bill

Behind the Bill
HHS Hits Reset on 340B Rebate Model After Court Setbacks
02/11/2026
Juliet Gallagher
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and...
02/11/2026
First Report Managed Care
Behind the Bill
Funding Package Extends Medicare Telehealth, Enacts PBM Reforms, and Updates Hospital Oversight
02/05/2026
Juliet Gallagher
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President...
02/05/2026
First Report Managed Care
Behind the Bill
The Senate’s $3 Trillion Deal. Tax Relief Now, Medicaid Coverage Loss Later?
07/02/2025
Katie Hayes, MJ
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After...
07/02/2025
First Report Managed Care
Behind the Bill
When a Cap Isn’t Just a Cap: How a Provider Tax Proposal Could Reshape Medicaid Financing
06/25/2025
Katie Hayes, MJ
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most...
06/25/2025
First Report Managed Care
Behind the Bill
Rewriting the Safety Net? Inside the Senate’s Changes to Medicaid and the ACA
06/18/2025
Katie Hayes, MJ
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve...
06/18/2025
First Report Managed Care
Behind the Bill
How States Might Respond to the One Big Beautiful Bill Act
06/11/2025
Katie Hayes, MJ
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill...
06/11/2025
First Report Managed Care
Behind the Bill
Is the Affordable Care Act on the Chopping Block? What the One Big Beautiful Bill Act Tells Us.
06/04/2025
Katie Hayes, MJ
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of...
06/04/2025
First Report Managed Care
Behind the Bill
From House to Senate: The Journey of Cutting Medicaid
05/28/2025
Katie Hayes, MJ
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of...
05/28/2025
First Report Managed Care
Behind the Bill
Eligibility, Paperwork, and Penalties: The Not-So-Hidden Costs of Medicaid ‘Reform’
05/21/2025
Katie Hayes, MJ
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week...
05/21/2025
First Report Managed Care
Behind the Bill
A Busy Week in Drug Pricing Policy: Aligning US Drug Prices With Global Standards?
05/14/2025
Katie Hayes, MJ
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for...
05/14/2025
First Report Managed Care

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use